Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
108.8 USD | -0.98% | +0.10% | +0.50% |
May. 14 | Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM | |
Apr. 30 | TD Cowen Adjusts Price Target on Revvity to $130 From $123 | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- One of the major weak points of the company is its financial situation.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 55.15 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.50% | 13.56B | B+ | ||
+8.38% | 220B | B | ||
+15.78% | 198B | B- | ||
+31.27% | 112B | A- | ||
+4.94% | 66.17B | A- | ||
+14.19% | 52.47B | B+ | ||
+4.70% | 50.77B | B+ | ||
-3.93% | 38.97B | A | ||
-0.47% | 35.13B | - | ||
+23.96% | 31.32B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- RVTY Stock
- Ratings Revvity, Inc.